Perturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*

Background: Nur77 expression is regulated by MEF2D, which is found to be associated with the calpain-CDK5-MEF2D neuronal death pathway. Results: Nur77 deficiency results in hypersensitivity to neuronal toxicity with Nur77 expression rescuing this loss. Conclusion: Nur77 reduces toxic neuronal insult regulated by the calpain-CDK5-MEF2 pathway. Significance: Previously reported calpain-CDK5-MEF2 signaling is now further elucidated with regulation of Nur77 in dopaminergic neuronal loss. We have earlier reported the critical nature of calpain-CDK5-MEF2 signaling in governing dopaminergic neuronal loss in vivo. CDK5 mediates phosphorylation of the neuronal survival factor myocyte enhancer factor 2 (MEF2) leading to its inactivation and loss. However, the downstream factors that mediate MEF2-regulated survival are unknown. Presently, we define Nur77 as one such critical downstream survival effector. Following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment in vivo, Nur77 expression in the nigrostriatal region is dramatically reduced. This loss is attenuated by expression of MEF2. Importantly, MEF2 constitutively binds to the Nur77 promoter in neurons under basal conditions. This binding is lost following 1-methyl-4-phenylpyridinium treatment. Nur77 deficiency results in significant sensitization to dopaminergic loss following 1-methyl-4-phenylpyridinium/MPTP treatment, in vitro and in vivo. Furthermore, Nur77-deficient MPTP-treated mice displayed significantly reduced levels of dopamine and 3,4-Dihydroxyphenylacetic acid in the striatum as well as elevated post synaptic FosB activity, indicative of increased nigrostriatal damage when compared with WT MPTP-treated controls. Importantly, this sensitization in Nur77-deficient mice was rescued with ectopic Nur77 expression in the nigrostriatal system. These results indicate that the inactivation of Nur77, induced by loss of MEF2 activity, plays a critical role in nigrostriatal degeneration in vivo.

[1]  C. Sheline,et al.  Mitochondrial Inhibitor Models of Huntington’s Disease and Parkinson’s Disease Induce Zinc Accumulation and Are Attenuated by Inhibition of Zinc Neurotoxicity in vitro or in vivo , 2012, Neurodegenerative Diseases.

[2]  Mark A Sussman,et al.  Mitochondrial translocation of Nur77 mediates cardiomyocyte apoptosis. , 2011, European heart journal.

[3]  D. Linseman,et al.  Calpain Plays a Central Role in 1-Methyl-4-phenylpyridinium (MPP(+))-Induced Neurotoxicity in Cerebellar Granule Neurons , 2011, Neurotoxicity Research.

[4]  H. Haniu,et al.  Nanoparticle-mediated intracellular lipid accumulation during C2C12 cell differentiation. , 2011, Biochemical and biophysical research communications.

[5]  Y. Smith,et al.  Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients. , 2011, The Journal of clinical investigation.

[6]  E. Yoo,et al.  6-Hydroxydopamine-Induced PC12 Cell Death is Mediated by MEF2D Down-regulation , 2011, Neurochemical Research.

[7]  D. Bruemmer,et al.  NR4A orphan nuclear receptors: transcriptional regulators of gene expression in metabolism and vascular biology. , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[8]  David S. Park,et al.  The role of Cdk5-mediated apurinic/apyrimidinic endonuclease 1 phosphorylation in neuronal death , 2010, Nature Cell Biology.

[9]  D. Surmeier,et al.  MEF-2 regulates activity-dependent spine loss in striatopallidal medium spiny neurons , 2010, Molecular and Cellular Neuroscience.

[10]  H. Roderick,et al.  CREB‐dependent Nur77 induction following depolarization in PC12 cells and neurons is modulated by MEF2 transcription factors , 2010, Journal of neurochemistry.

[11]  David S. Park,et al.  Pim‐1 kinase as activator of the cell cycle pathway in neuronal death induced by DNA damage , 2010, Journal of neurochemistry.

[12]  L. Grégoire,et al.  Nur77 mRNA levels and L-Dopa-induced dyskinesias in MPTP monkeys treated with docosahexaenoic acid , 2009, Neurobiology of Disease.

[13]  Z. Mao,et al.  Phosphorylation of Neuronal Survival Factor MEF2D by Glycogen Synthase Kinase 3β in Neuronal Apoptosis* , 2009, The Journal of Biological Chemistry.

[14]  P. Tontonoz,et al.  Inhibition of adipocyte differentiation by Nur77, Nurr1, and Nor1. , 2008, Molecular endocrinology.

[15]  E. Verdin,et al.  HDAC7 regulates apoptosis in developing thymocytes. , 2008, Novartis Foundation symposium.

[16]  J. Arthur,et al.  ERK5 regulation in naïve T‐cell activation and survival , 2008, European Journal of Immunology.

[17]  A. Winoto,et al.  During negative selection, Nur77 family proteins translocate to mitochondria where they associate with Bcl-2 and expose its proapoptotic BH3 domain , 2008, The Journal of experimental medicine.

[18]  S. Matsuda,et al.  ERK5 is involved in TCR‐induced apoptosis through the modification of Nur77 , 2008, Genes to cells : devoted to molecular & cellular mechanisms.

[19]  Zidong Zhang,et al.  Nur77 coordinately regulates expression of genes linked to glucose metabolism in skeletal muscle. , 2007, Molecular endocrinology.

[20]  David S. Park,et al.  Role of Cdk5-Mediated Phosphorylation of Prx2 in MPTP Toxicity and Parkinson's Disease , 2007, Neuron.

[21]  Sylvie Faucher,et al.  Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons , 2007, The Journal of Neuroscience.

[22]  S. Przedborski,et al.  Protocol for the MPTP mouse model of Parkinson's disease , 2007, Nature Protocols.

[23]  D. Lévesque,et al.  Nur77 and retinoid X receptors: crucial factors in dopamine-related neuroadaptation , 2007, Trends in Neurosciences.

[24]  S. Hamilton,et al.  Nur77 agonists induce proapoptotic genes and responses in colon cancer cells through nuclear receptor-dependent and nuclear receptor-independent pathways. , 2007, Cancer research.

[25]  D. Lévesque,et al.  Nur77 Gene Knockout Alters Dopamine Neuron Biochemical Activity and Dopamine Turnover , 2006, Biological Psychiatry.

[26]  David S. Park,et al.  The Chk1/Cdc25A Pathway as Activators of the Cell Cycle in Neuronal Death Induced by Camptothecin , 2006, The Journal of Neuroscience.

[27]  D. Lévesque,et al.  Impaired behavioural and molecular adaptations to dopamine denervation and repeated L‐DOPA treatment in Nur77‐knockout mice , 2006, The European journal of neuroscience.

[28]  F. Denis,et al.  Inhibition of apoptosis by Nur77 through NF-κB activity modulation , 2006, Cell Death and Differentiation.

[29]  David S. Park,et al.  Calpain-Regulated p35/cdk5 Plays a Central Role in Dopaminergic Neuron Death through Modulation of the Transcription Factor Myocyte Enhancer Factor 2 , 2006, The Journal of Neuroscience.

[30]  David S. Park,et al.  Differential Roles of Nuclear and Cytoplasmic Cyclin-Dependent Kinase 5 in Apoptotic and Excitotoxic Neuronal Death , 2005, The Journal of Neuroscience.

[31]  M. Pallàs,et al.  Inhibition of the cdk5/MEF2 pathway is involved in the antiapoptotic properties of calpain inhibitors in cerebellar neurons , 2005, British journal of pharmacology.

[32]  Z. Mao,et al.  Regulation of Neuroprotective Activity of Myocyte-enhancer Factor 2 by cAMP-Protein Kinase A Signaling Pathway in Neuronal Survival* , 2005, Journal of Biological Chemistry.

[33]  K. Heidenreich,et al.  Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival , 2004, Molecular Neurobiology.

[34]  David S. Park,et al.  Regulation of Dopaminergic Loss by Fas in a 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Model of Parkinson's Disease , 2004, The Journal of Neuroscience.

[35]  John Calvin Reed,et al.  Conversion of Bcl-2 from Protector to Killer by Interaction with Nuclear Orphan Receptor Nur77/TR3 , 2004, Cell.

[36]  A. Sadikot,et al.  Neurogenesis and stereological morphometry of calretinin‐immunoreactive GABAergic interneurons of the neostriatum , 2004, The Journal of comparative neurology.

[37]  E. Bézard,et al.  Time-course of nigrostriatal degeneration in a progressive MPTP-lesioned macaque model of parkinson’s disease , 2003, Molecular Neurobiology.

[38]  David S. Park,et al.  Cyclin-dependent kinase 5 is a mediator of dopaminergic neuron loss in a mouse model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  David S. Park,et al.  Calpains Mediate p53 Activation and Neuronal Death Evoked by DNA Damage* , 2003, Journal of Biological Chemistry.

[40]  T. Mak,et al.  Nur77 as a survival factor in tumor necrosis factor signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[41]  D. Green,et al.  Activation‐induced cell death in T cells , 2003, Immunological reviews.

[42]  V. Kiermer,et al.  HDAC7, a thymus-specific class II histone deacetylase, regulates Nur77 transcription and TCR-mediated apoptosis. , 2003, Immunity.

[43]  Junmin Peng,et al.  Cdk5-Mediated Inhibition of the Protective Effects of Transcription Factor MEF2 in Neurotoxicity-Induced Apoptosis , 2003, Neuron.

[44]  H. Anisman,et al.  Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice , 2003, Neurobiology of Disease.

[45]  You-Wen He.  Orphan nuclear receptors in T lymphocyte development , 2002, Journal of leukocyte biology.

[46]  E. Olson,et al.  Control of muscle development by dueling HATs and HDACs. , 2001, Current opinion in genetics & development.

[47]  L. Tsai,et al.  p35 and p39 Are Essential for Cyclin-Dependent Kinase 5 Function during Neurodevelopment , 2001, The Journal of Neuroscience.

[48]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[49]  H. Youn,et al.  Thapsigargin‐induced apoptosis involves Cabin1‐MEF2‐mediated induction of Nur77 , 2001, European journal of immunology.

[50]  H. Youn,et al.  Cabin1 represses MEF2-dependent Nur77 expression and T cell apoptosis by controlling association of histone deacetylases and acetylases with MEF2. , 2000, Immunity.

[51]  C. Martínez-A,et al.  Ceramide-induced cell death is independent of the Fas/Fas ligand pathway and is prevented by Nur77 overexpression in A20 B cells , 2000, Cell Death and Differentiation.

[52]  H. Youn,et al.  Apoptosis of T cells mediated by Ca2+-induced release of the transcription factor MEF2. , 1999, Science.

[53]  M E Greenberg,et al.  Neuronal activity-dependent cell survival mediated by transcription factor MEF2. , 1999, Science.

[54]  P. Beart,et al.  Development and survival of rat embryonic mesencephalic dopaminergic neurones in serum-free, antioxidant-rich primary cultures , 1997, Neuroscience Letters.

[55]  B. Calnan,et al.  Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis , 1995, Molecular and cellular biology.

[56]  G. Linette,et al.  Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). , 1995, Science.

[57]  R. Faull,et al.  Prolonged expression of Fos-related antigens, Jun B and TrkB in dopamine-denervated striatal neurons. , 1995, Brain research. Molecular brain research.

[58]  J. Milbrandt,et al.  Growth and Differentiation Proceeds Normally in Cells Deficient in the Immediate Early Gene NGFI-A (*) , 1995, The Journal of Biological Chemistry.

[59]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[60]  L. Tsai,et al.  Activity and expression pattern of cyclin-dependent kinase 5 in the embryonic mouse nervous system. , 1993, Development.

[61]  J. Pines,et al.  Cyclins and cyclin-dependent kinases: take your partners , 1993 .

[62]  V. Kostic,et al.  Early development of levodopa‐induced dyskinesias and response fluctuations in young‐onset Parkinson's disease , 1991, Neurology.

[63]  H. J. G. Gundersen,et al.  The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis , 1988, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[64]  J. Milbrandt.  Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene , 1988, Neuron.

[65]  David S. Park,et al.  Involvement of interferon-gamma in microglial-mediated loss of dopaminergic neurons. , 2007, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[66]  M. Vila,et al.  The last decade in Parkinson's disease research. Basic sciences. , 2001, Advances in neurology.